Healthcare - Biotechnology - NASDAQ - US
$ 1.87
-5.08 %
$ 132 M
Market Cap
-0.8
P/E
BALANCE SHEET
278 M
ASSETS
33.8 M
LIABILITIES
244 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Ventyx Biosciences, Inc.
| Current Assets | 264 M |
| Cash & Short-Term Investments | 252 M |
| Receivables | 0 |
| Other Current Assets | 12.1 M |
| Non-Current Assets | 13.3 M |
| Long-Term Investments | 0 |
| PP&E | 12.3 M |
| Other Non-Current Assets | 1.08 M |
| Current Liabilities | 22.3 M |
| Accounts Payable | 5.76 M |
| Short-Term Debt | 1 M |
| Other Current Liabilities | 15.5 M |
| Non-Current Liabilities | 11.5 M |
| Long-Term Debt | 11.5 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 51.6 | 64.8 | 70.8 | 0.2 | 0.3 |
| Short Term Investments | 200.6 | 253.1 | 187.8 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.1 | 12.7 | 4.4 | 1 K | 40 K |
| Total Current Assets | 264.3 | 330.7 | 263.0 | 0.2 | 0.3 |
| PP&E | 12.3 | 1.9 | 0.3 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 38.7 | 28.1 | 0 | 0 |
| Other Long Term Assets | 1.1 | 96 K | 60 K | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 277.7 | 371.4 | 291.5 | 0.2 | 0.3 |
| LIABILITIES | |||||
| Accounts Payable | 5.8 | 6.4 | 4.7 | 1.1 | 0.4 |
| Short Term Debt | 1.0 | 0.8 | 0 | 0 | 0 |
| Other Current Liabilities | 15.5 | 9.1 | 7.6 | 0.3 | 0.3 |
| Total Current Liabilities | 22.3 | 16.4 | 12.3 | 1.4 | 0.6 |
| Long Term Debt | 11.5 | 1.1 | 0 | 12.6 | 3.8 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 16.8 | 0 |
| Total Liabilities | 33.8 | 17.5 | 12.3 | 30.9 | 4.5 |
| EQUITY | |||||
| Common Stock | 6 K | 6 K | 5 K | 0 | 0 |
| Retained Earnings | (419.2) | (226.2) | (117.8) | (32.5) | (4.3) |
| Other Accumulative Comprehensive Income/Loss | 50 K | (1.1) | 58 K | 0 | 0 |
| Total Equity | 243.9 | (226.2) | (117.8) | (30.7) | (4.1) |
| Total Liabilities and Equity | 277.7 | (208.7) | (105.5) | 0.2 | 0.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 58.5 | 52.5 | 50.4 | 50.3 | 50.3 |